Haemonetics (HAE) Depreciation and Depletion (2018 - 2026)

Haemonetics' Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion rose 0.66% year-over-year to $15.3 million; the TTM figure through Mar 2026 stood at $61.1 million (up 1.83% YoY), while the FY2026 annual figure was $61.2 million, up 2.0% from the prior year.
• Depreciation and Depletion was $15.3 million for Q1 2026 at Haemonetics, up from $14.9 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $15.5 million in Q3 2025 to a low of $11.7 million in Q3 2022.
• Historically, Depreciation and Depletion has averaged $14.3 million across 5 years, with a median of $14.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Depreciation and Depletion climbed 13.68% in 2023, then retreated 1.97% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $13.1 million in 2022, then climbed by 8.4% to $14.2 million in 2023, then grew by 7.04% to $15.2 million in 2024, then slipped by 1.97% to $14.9 million in 2025, then grew by 2.68% to $15.3 million in 2026.
• The last three Depreciation and Depletion figures came in at $15.3 million (Q1 2026), $14.9 million (Q4 2025), and $15.5 million (Q3 2025), per Business Quant data.